All In MedTech

FDA Clearance Tracker · K201618

Nalu Neurostimulation SCS system

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Jul 15, 2020 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Jul 15, 2020

Substantially Equivalent

Time to decision

30 days

Received Jun 15, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Special

Device class

Class II

The decision

FDA number
K201618
Device name
Nalu Neurostimulation SCS system
Applicant location
Valencia, CA
Received
Jun 15, 2020
Decided
Jul 15, 2020
Decision
Substantially Equivalent
Submission type
Special

Device type

Device class
Class II
Regulation
21 CFR 882.5880

Every decision under product code GZB

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code GZB. The earliest in FDA's data is K780001, decided Jan 17, 1978.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Boston Scientific Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.